- Vouliez-vous dire
- disease progress
Résultats de la recherche - 2 results
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Therapy COVID-19 Female Global Burden of Disease Hospitalization Humans Immunization, Passive Male mortality Respiration, Artificial SAFETY SARS-CoV-2 Standard of Care Treatment Outcome Abstract: ...
Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in Belgium.
Lode; Molenberghs, Geert Source: Int J Environ Res Public Health, Volume 18, Issue 23 (2021) Keywords: Belgium Communicable Disease Control COVID-19 Humans Occupations SARS-CoV-2 Abstract: Some ...